Procalcitonin to guide duration of antibiotic therapy in intensive care patients: A randomized prospective controlled trial.
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Introduction: The development of resistance by bacterial species is a compelling issue to reconsider indications and administration of antibiotic treatment. Adequate indications and duration of therapy are particularly important for the use of highly potent substances in the intensive care setting. Until recently, no laboratory marker has been available to differentiate bacterial infection from viral or non-infectious inflammatory reaction; however, over the past years, procalcitonin (PCT) is the first among a large array of inflammatory variables that offers this possibility. The present study aimed to investigate the clinical usefulness of PCT for guiding antibiotic therapy in surgical intensive care patients. Methods: All patients requiring antibiotic therapy based on confirmed or highly suspected bacterial infections and at least two concomitant systemic inflammatory response syndrome criteria were eligible. Patients were randomly assigned to either a PCT-guided (study group) or a standard (control group) antibiotic regimen. Antibiotic therapy in the PCT-guided group was discontinued, if clinical signs and symptoms of infection improved and PCT decreased to <1 ng/ml or the PCT value was >1 ng/ml, but had dropped to 25 to 35% of the initial value over three days. In the control group antibiotic treatment was applied as standard regimen over eight days. Results: A total of 110 surgical intensive care patients receiving antibiotic therapy after confirmed or high-grade suspected infections were enrolled in this study. In 57 patients antibiotic therapy was guided by daily PCT and clinical assessment and adjusted accordingly. The control group comprised 53 patients with a standardized duration of antibiotic therapy over eight days. Demographic and clinical data were comparable in both groups. However, in the PCT group the duration of antibiotic therapy was significantly shorter than compared to controls (5.9 +/- 1.7 versus 7.9 +/- 0.5 days, P < 0.001) without negative effects on clinical outcome. Conclusions: Monitoring of PCT is a helpful tool for guiding antibiotic treatment in surgical intensive care patients. This may contribute to an optimized antibiotic regimen with beneficial effects on microbial resistance and costs in intensive care medicine. Annotation: Results were previously published in German in Anaesthesist 2008; 57: 571–577 (PMID: 18463831). Trial registration: ISRCTN10288268
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
(2013) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/103.1437-1588 · Cited by 11,796
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674 · cited 1×
“In addition, Sequential Organ Failure Assessment (SOFA) scores were calculated daily [16] to stratify and monitor disease severity.”
MethodKumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109 · cited 3×
“Accordingly, Kumar and colleagues [1] could show that the hospital mortality rate for patients with septic shock increased by about 7% per hour within the first six hours of delayed antibiotic administration.”
BackgroundChastre, J., Wolff, M., Fagon, J.-Y., Chevret, S., Thomas, F., Wermert, D., Clementi, E., Gonzalez, J., Jusserand, D., Asfar, P., et al. (2003) · JAMA · doi:10.1001/jama.290.19.2588 · Cited by 1,376
SINGH, N., ROGERS, P., ATWOOD, C. W., WAGENER, M. M., & YU, V. L. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9909095 · Cited by 1,032 · cited 3×
“Singh and colleagues [12] investigated intensive care patients with pneumonia and found that discontinuing antibiotic treatment after three days in the absence of a suspected infection did not worsen outcome.”
BackgroundIregui, M., Ward, S., Sherman, G., Fraser, V. J., & Kollef, M. H. (2002) · Chest · doi:10.1378/chest.122.1.262 · Cited by 956 · cited 1×
“A study from the USA was able to demonstrate that patients with ventilator-associated pneumonia who received antibiotic therapy only 24 hours after established diagnosis, exhibited a seven times higher mortality rate compared with patients started on adequate therapy earlier [21].”
ResultHARBARTH, S., HOLECKOVA, K., FROIDEVAUX, C., PITTET, D., RICOU, B., GRAU, G. E., VADAS, L., PUGIN, J., & the Geneva Sepsis Network (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.3.2009052 · Cited by 898
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Barlam, T. F., Cosgrove, S. E., Abbo, L. M., MacDougall, C., Schuetz, A. N., Septimus, E. J., Srinivasan, A., Dellit, T. H., Falck-Ytter, Y. T., Fishman, N. O., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw118 · Cited by 3,061
“PAF has also been effective in the ICU [24, 25].”
InfluentialSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Interventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Brown, E., Charani, E., Fenelon, L., Gould, I. M., Holmes, A., Ramsay, C. R., Wiffen, P. J., & Wilcox, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub3 · Cited by 1,864
Bouadma, L., Luyt, C.-E., Tubach, F., Cracco, C., Alvarez, A., Schwebel, C., Schortgen, F., Lasocki, S., Veber, B., Dehoux, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61879-1 · Cited by 1,183
Interventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Marwick, C. A., Scott, C. L., Charani, E., McNeil, K., Brown, E., Gould, I. M., Ramsay, C. R., & Michie, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub4 · Cited by 1,068
de Jong, E., van Oers, J. A., Beishuizen, A., Vos, P., Vermeijden, W. J., Haas, L. E., Loef, B. G., Dormans, T., van Melsen, G. C., Kluiters, Y. C., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00053-0 · Cited by 836
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Schuetz, P., Wirz, Y., Sager, R., Christ-Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007498.pub3 · Cited by 649
Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future
Schuetz, P., Albrich, W., & Mueller, B. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-107 · Cited by 528
“infections in the post-operative course [64,65].”
BackgroundNew Approaches to Sepsis: Molecular Diagnostics and Biomarkers
Reinhart, K., Bauer, M., Riedemann, N. C., & Hartog, C. S. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-12 · Cited by 533
“One larger multicenter study and two smaller monocentric studies of postsurgical patients also confirmed a reduction of antibiotic exposure by procalcitonin use in the ICU setting (35, 109, 242).”
Schuetz, P., Wirz, Y., Sager, R., Christ-Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30592-3 · Cited by 486
Diagnostic and prognostic biomarkers of sepsis in critical care
Kibe, S., Adams, K., & Barlow, G. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq523 · Cited by 414
Schuetz, P. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.318 · Cited by 386
2023 Update on Sepsis and Septic Shock in Adult Patients: Management in the Emergency Department
Guarino, M., Perna, B., Cesaro, A. E., Maritati, M., Spampinato, M. D., Contini, C., & De Giorgio, R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093188 · Cited by 294
Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target
Becker, K. L., Snider, R., & Nylen, E. S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00433.x · Cited by 309
“…in hospitalized patients with community-acquired pneumonia (Christ-Crain et al., 2006) and in exacerbations of chronic obstructive pulmonary disease (Stolz et al., 2007), and may have shortened the duration of treatment in patients with sepsis (Nobre et al., 2008; Hochreiter et al., 2009).”
BackgroundPugh, R., Grant, C., Cooke, R. P., & Dempsey, G. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007577.pub3 · Cited by 289
Schuetz, P., Briel, M., Christ-Crain, M., Stolz, D., Bouadma, L., Wolff, M., Luyt, C.-E., Chastre, J., Tubach, F., Kristoffersen, K. B., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis464 · Cited by 280
“Hochreiter (2009) [22] No (unconcealed drawing of lots) No 43/43 (100% until discharge) Not reported”
BackgroundWirz, Y., Meier, M. A., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., Tubach, F., Schroeder, S., Nobre, V., Annane, D., et al. (2018) · Critical Care · doi:10.1186/s13054-018-2125-7 · Cited by 265
“Hochreiter (2009) [14] Germany Surgical ICU, single center 110 Hospital stay Sepsis (SIRS and documented infection) Duration; R against AB: < 1 or > 65% drop over 3 days not reported”
BackgroundProcalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Schuetz, P., Müller, B., Christ-Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., Tubach, F., et al. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007498.pub2 · Cited by 264
Prkno, A., Wacker, C., Brunkhorst, F. M., & Schlattmann, P. (2013) · Critical Care · doi:10.1186/cc13157 · Cited by 260
“For PCT measurements three different PCT tests were used: Brahms PCT Kryptor [26,27,29,30], Brahms PCT LIA [28,31] and Brahms PCT-Q [32].”
BackgroundMethodInfluentialKopterides, P., Siempos, I. I., Tsangaris, I., Tsantes, A., & Armaganidis, A. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181f17bf9 · Cited by 250
“Plasma PCT concentrations were measured using the ultrasensitive timeresolved amplified cryptate emission technology assay (PCT Kryptor; Brahms AG, Henningsdorf, Germany) in four studies (31, 32, 35, 37) and the less sensitive luminescence immunoassay (PCT LIA; Brahms AG) in two studies (33, 34).”
BackgroundMethodInfluentialEgi, M., Ogura, H., Yatabe, T., Atagi, K., Inoue, S., Iba, T., Kakihana, Y., Kawasaki, T., Kushimoto, S., Kuroda, Y., et al. (2021) · Journal of Intensive Care · doi:10.1186/s40560-021-00555-7 · Cited by 224
Oliveira, C. F., Botoni, F. A., Oliveira, C. R. A., Silva, C. B., Pereira, H. A., Serufo, J. C., & Nobre, V. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31828e969f · Cited by 213
Heyland, D. K., Johnson, A. P., Reynolds, S. C., & Muscedere, J. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31821201a5 · Cited by 213
“With the exception of the two RCTs from the same group (28, 29), all the studies used different arbitrarily derived decision rules to guide antibiotic discontinuation.”
BackgroundResultInfluentialShehabi, Y., Sterba, M., Garrett, P. M., Rachakonda, K. S., Stephens, D., Harrigan, P., Walker, A., Bailey, M. J., Johnson, B., Millis, D., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201408-1483oc · Cited by 201
Sartelli, M., Weber, D. G., Ruppé, E., Bassetti, M., Wright, B. J., Ansaloni, L., Catena, F., Coccolini, F., Abu-Zidan, F. M., Coimbra, R., et al. (2016) · World Journal of Emergency Surgery · doi:10.1186/s13017-016-0089-y · Cited by 197
“In the management of critically ill patients with sepsis and septic shock clinical signs and symptoms as well as inflammatory response markers such as procalcitonin, although debatable, may assist in guiding antibiotic treatment [293].”
BackgroundA focus on intra-abdominal infections
Sartelli, M. (2010) · World Journal of Emergency Surgery · doi:10.1186/1749-7922-5-9 · Cited by 172
“[148] published a prospective trial to value the role of procalcitonin for guiding antibiotic therapy in surgical intensive care patients.”
BackgroundAntimicrobial Stewardship Programs: Appropriate Measures and Metrics to Study their Impact
Morris, A. M. (2014) · Current Treatment Options in Infectious Diseases · doi:10.1007/s40506-014-0015-3 · Cited by 172
Role of procalcitonin use in the management of sepsis
Gregoriano, C., Heilmann, E., Molitor, A., & Schuetz, P. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.11.63 · Cited by 159
“In fact, PCT kinetics over time has shown to improve the monitoring of critically ill patients with sepsis (38-44).”
BackgroundKarlsson, S., Heikkinen, M., Pettilä, V., Alila, S., Väisänen, S., Pulkki, K., Kolho, E., Ruokonen, E., & the Finnsepsis Study Group (2010) · Critical Care · doi:10.1186/cc9327 · Cited by 168
“However, in critically ill patients, PCT-guided termination of antibiotic treatment was used without worsening outcome [19,45].”
BackgroundMethodHamade, B., & Huang, D. T. (2020) · Critical Care Clinics · doi:10.1016/j.ccc.2019.08.003 · Cited by 160
suPAR as a prognostic biomarker in sepsis
Donadello, K., Scolletta, S., Covajes, C., & Vincent, J.-L. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-2 · Cited by 162
“Hence, being able to follow response to therapy and guide antimicrobial use could be of value, as has been suggested for other biomarkers [37].”
BackgroundDusemund, F. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.770 · Cited by 167
Interpretation of C-Reactive Protein Concentrations in Critically Ill Patients
Lelubre, C., Anselin, S., Zouaoui Boudjeltia, K., Biston, P., & Piagnerelli, M. (2013) · BioMed Research International · doi:10.1155/2013/124021 · Cited by 158
“The time course of CRP as a marker of appropriate treatment, as has been suggested for PCT [32, 71], and as a marker for the end of infection is of potential interest, although few studies have reported these aspects during sepsis.”
BackgroundInfluentialProcalcitonin for guidance of antibiotic therapy
Schüetz, P., Albrich, W. C., Christ‐Crain, M., Chastre, J. E., & Müeller, B. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.25 · Cited by 158
Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial
Kyriazopoulou, E., Liaskou-Antoniou, L., Adamis, G., Panagaki, A., Melachroinopoulos, N., Drakou, E., Marousis, K. D., Chrysos, G., Spyrou, A., Alexiou, N., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202004-1201oc · Cited by 161
Schüetz, P., Maurer, P., Punjabi, V., Desai, A., Amin, D., & Gluck, E. H. (2013) · Critical Care · doi:10.1186/cc12787 · Cited by 154
Strategies for Reduction in Duration of Antibiotic Use in Hospitalized Patients
Hayashi, Y., & Paterson, D. L. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir063 · Cited by 147
“Published RCTs of Procalcitonin (PCT)–Guided Antimicrobial Treatment in Adults Primary investigator (year) Journal [reference] Type of infection Country (institution) PCT assay method N PCT used for initiation of antibiotics PCT used for discontinuation of antibiotics Antibiotic use Clinical outcome Christ-Crain (2004…”
BackgroundInfluentialEvaluation of potential biomarkers for the discrimination of bacterial and viral infections
Chalupa, P., Beran, O., Herwald, H., Kaspříková, N., & Holub, M. (2011) · Infection · doi:10.1007/s15010-011-0126-4 · Cited by 137
“This result supports findings from previous studies, where elevated PCT values indicated systemic bacterial infections [ 17 , 18].”
ResultWestwood, M., Ramaekers, B., Whiting, P., Tomini, F., Joore, M., Armstrong, N., Ryder, S., Stirk, L., Severens, J., & Kleijnen, J. (2015) · Health Technology Assessment · doi:10.3310/hta19960 · Cited by 138
Procalcitonin-Guided Antibiotic Discontinuation and Mortality in Critically Ill Adults
Pepper, D. J., Sun, J., Rhee, C., Welsh, J. A., Powers, J. H., Danner, R. L., & Kadri, S. S. (2019) · CHEST Journal · doi:10.1016/j.chest.2018.12.029 · Cited by 154
“Investigators concluded that PCT-based algorithms could potentially save government health systems millions of euros annually,(48) based on a decision tree analysis of six RCTs.(19-23,30) However, these six RCTs all had high or unknown risk of bias and do not mention whether an antibiotic stewardship program was used…”
BackgroundMethodMatthaiou, D. K., Ntani, G., Kontogiorgi, M., Poulakou, G., Armaganidis, A., & Dimopoulos, G. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2563-7 · Cited by 138
“Lastly, in some cases there was no consistency, especially regarding mortality, for which two of the studies report on total mortality [19, 20], whereas the rest report on 28-day mortality, in the reported outcomes between the studies.”
BackgroundResultInfluentialProcalcitonin Monitoring as a Guide for Antimicrobial Therapy: A Review of Current Literature
Covington, E. W., Roberts, M. Z., & Dong, J. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2112 · Cited by 135
Using Procalcitonin to Guide Antibiotic Therapy
Rhee, C. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw249 · Cited by 127
“Small, single-center studies in medical-surgical or surgical ICUs in Switzerland and Germany first demonstrated that procalcitonin used in this manner could safely reduce antibiotic therapy in patients with suspected sepsis [17, 28, 29].”
BackgroundProcalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Schüetz, P., Müller-Stich, B. P., Christ‐Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J. E., Tubach, F., et al. (2013) · Evidence-Based Child Health A Cochrane Review Journal · doi:10.1002/ebch.1927 · Cited by 132
De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock
Silva, B. N., Andriolo, R. B., Atallah, Á. N., & Salomão, R. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007934.pub3 · Cited by 107
Iankova, I., Thompson-Leduc, P., Kirson, N. Y., Rice, B., Hey, J., Krause, A., Schonfeld, S. A., DeBrase, C. R., Bozzette, S., & Schuetz, P. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000002928 · Cited by 106
“The time horizon for mortality varied between studies: while four studies reported mortality during the patient’s stay in the ICU (24, 27, 29, 33), three studies reported mortality during the patient’s hospital stay (28, 30, 32), and three studies reported 28-day mortality (25, 26, 31).”
BackgroundInfluentialAgarwal, R. K., & Schwartz, D. N. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir408 · Cited by 117
“The single negative study [15] assessed the impact of PCT guidance solely for the decision to initiate antimicrobial therapy, whereas the 4 studies that used PCT levels to guide antimicrobial duration alone [10, 11, 14, 16]”
BackgroundMethodResultInfluentialDupuy, A., Philippart, F., Pean, Y., Lasocki, S., Charles, P., Chalumeau, M., Claessens, Y.-É., Quenot, J., Guen, C. G., Ruiz, S., et al. (2013) · Annals of Intensive Care · doi:10.1186/2110-5820-3-22 · Cited by 109
“Four of these studies enrolled more than 900 patients hospitalised in intensive care or highdependency units [18-21].”
Backgroundfor the BPCTrea Study Group, Daubin, C., Valette, X., Thiollière, F., Mira, J. P., Hazera, P., Annane, D., Labbé, V., Floccard, B., Fournel, F., et al. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5141-9 · Cited by 111
Biomarker discovery and development in pediatric critical care medicine*
Kaplan, J. M., & Wong, H. R. (2010) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3181e28876 · Cited by 113
“In a randomized control trial, patients were divided into a PCT-guided treatment plan or a standard antibiotic treatment plan (42).”
MethodAndriolo, B. N., Andriolo, R. B., Salomão, R., & Atallah, Á. N. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010959.pub2 · Cited by 115
Albrich, W. C., & Harbarth, S. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3978-8 · Cited by 105
“In contrast, in all five studies in which antibiotic discontinuation was guided by PCT, antibiotic duration was significantly shorter in the PCT groups [25, 38, 40–43], for days alive off antibiotics, duration of first antimicrobial course, and total duration of antimicrobial”
BackgroundResultLong, W., Deng, X., Zhang, Y., Lü, G., Xie, J., & Tang, J. (2011) · Respirology · doi:10.1111/j.1440-1843.2011.01978.x · Cited by 97
Huang, H., Peng, J., Weng, L., Wang, C.-Y., Jiang, W., & Du, B. (2017) · Annals of Intensive Care · doi:10.1186/s13613-017-0338-6 · Cited by 101
“Study population included surgical patients (n = 3) [30, 31, 33] and mixed medical–surgical patients (n = 10) [13, 23, 24, 32, 34–39].”
Role of Procalcitonin in Managing Adult Patients With Respiratory Tract Infections
Schüetz, P., Amin, D., & Greenwald, J. L. (2012) · CHEST Journal · doi:10.1378/chest.11-2430 · Cited by 95
Deliberato, R. O., Marra, A. R., Sanches, P. R., Dalla Valle Martino, M., dos Santos Ferreira, C. E., Pasternak, J., Paes, A. T., Pinto, L. M., dos Santos, O. F. P., & Edmond, M. B. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.03.027 · Cited by 93
“Some markers of infectious activity are slow to return to normal, such as the leukocyte differential count and CRP (Hochreiter et al., 2009; Silvestre et al., 2009; Venkatesh et al., 2009).”
BackgroundMethodBiomarker-guided antibiotic therapy in adult critically ill patients: a critical review
Póvoa, P. M. S. R., & Salluh, J. I. (2012) · Annals of Intensive Care · doi:10.1186/2110-5820-2-32 · Cited by 112
“In four RCT, the algorithm was designed to assist in the decision to stop antibiotics [41,44-46], in two to assist in the decision to start and to stop antibiotics [42,43], and finally to start or escalate antibiotics [47].”
BackgroundMethodInfluentialHöhn, A., Schröder, S., Gehrt, A., Bernhardt, K., Bein, B., Wegscheider, K., & Hochreiter, M. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-158 · Cited by 100
“To our knowledge, so far, six randomised controlled trials assessed the utility of PCT in tailoring antibiotic therapy in septic ICU individuals [10,13,15-17,28].”
BackgroundMethodSelf-citationUusitalo‐Seppälä, R., Koskinen, P. J., Leino, A. E., Peuravuori, H. J., Vahlberg, T. J., & Rintala, E. M. (2011) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2011.600325 · Cited by 91
“Moreover, serial measurement of parameters may add to this evaluation, as it has recently been shown that serial PCT measurements can be used successfully in the guidance of antibiotic therapy [21,22].”
BackgroundMiedema, K. G. E., de Bont, E. S. J. M., Elferink, R. F. M. O., van Vliet, M. J., Nijhuis, C. S. M. O., Kamps, W. A., & Tissing, W. J. E. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-010-0987-6 · Cited by 100
Sridharan, P., & Chamberlain, R. S. (2013) · Surgical Infections · doi:10.1089/sur.2012.028 · Cited by 99
“…that patients in the PCT arm of their study required two fewer days of antibiotics (p < 0.001) than those the control arm, whereas Schroeder et al. found that the PCT intervention group in their study required 1.7 fewer days of antibiotic therapy than did the control group (p < 0.001) [73,74].”
InfluentialBiomarker-guided antibiotic therapy—strengths and limitations
Nora, D. G., Salluh, J. I., Martín‐Loeches, I., & Póvoa, P. M. S. R. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.04.04 · Cited by 96
Lam, S. W., Bauer, S. R., Fowler, R., & Duggal, A. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002953 · Cited by 95
Egi, M., Ogura, H., Yatabe, T., Atagi, K., Inoue, S., Iba, T., Kakihana, Y., Kawasaki, T., Kushimoto, S., Kuroda, Y., et al. (2021) · Acute Medicine & Surgery · doi:10.1002/ams2.659 · Cited by 96
O’Grady, N. P., Alexander, E., Alhazzani, W. A., Alshamsi, F. E., Cuellar‐Rodríguez, J., Jefferson, B. K., Kalil, A. C., Pastores, S. M., Patel, R., van Duin, D., et al. (2023) · Critical Care Medicine · doi:10.1097/ccm.0000000000006022 · Cited by 95
“In ICU patients with suspected sepsis, clinicians should not initially with-hold antibiotics, but PCT levels of less than 0.5 µg/L or levels that decrease by greater than or equal to 80% from peak levels may guide antibiotic discontinuation once patients stabilize (106–110).”
BackgroundInfluentialFDA-Authorized AI/ML Tool for Sepsis Prediction: Development and Validation
Bhargava, A., López-Espina, C., Schmalz, L., Khan, S., Watson, G. L., Urdiales, D., Updike, L., Kurtzman, N., Dagan, A., Doodlesack, A., et al. (2024) · NEJM AI · doi:10.1056/aioa2400867 · Cited by 72
Procalcitonin‐guided antibiotic therapy: A systematic review and meta‐analysis
Soni, N. J., Samson, D. J., Galaydick, J., Vats, V., Huang, E. S., Aronson, N., & PITRAK, D. L. (2013) · Journal of Hospital Medicine · doi:10.1002/jhm.2067 · Cited by 85
Chu, D., Mehta, A., & Walkey, A. J. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix179 · Cited by 82
Procalcitonin to guide antibiotic therapy in the ICU
Bréchot, N., Hékimian, G., Chastre, J. E., & Luyt, C. E. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.10.012 · Cited by 83
Diagnostic use of serum procalcitonin levels in pulmonary aspiration syndromes*
El-Solh, A., Vora, H., Knight, P. R., & Porhomayon, J. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31820a942c · Cited by 73
Schüetz, P., Bretscher, C., Bernasconi, L., & Müeller, B. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1324299 · Cited by 78
Rawahi, A. A., Alhinai, F., Doig, C. J., Ball, C. G., Dixon, E., Xiao, Z. J., & Kirkpatrick, A. W. (2019) · Critical Care · doi:10.1186/s13054-019-2669-1 · Cited by 83
BALK, R. A., Kadri, S. S., Cao, Z., Robinson, S. B., Lipkin, C. B., & Bozzette, S. A. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.06.046 · Cited by 69
Papp, M., Kiss, N., Baka, M., Trásy, D., Zubek, L., Fehérvári, P., Harnos, A., Turan, C., Hegyi, P. J., & Molnár, Z. (2023) · Critical Care · doi:10.1186/s13054-023-04677-2 · Cited by 89
“Data on populations including only surgical patients were insufficient for meta-analysis, but pooling data from two surgical cohorts [51, 52] results in an even more pronounced reduction in the length of AB therapy.”
BackgroundMethodBiomarker‐Guided Individualization of Antibiotic Therapy
Aulin, L. B. S., de Lange, D. W., Saleh, M. A. A., van der Graaf, P. H., Völler, S., & van Hasselt, J. G. C. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2194 · Cited by 76
“14 20 The relative change in PCT has been successfully used to guide antibiotic treatment duration, 21,22 illustrating the relevance of considering the dynamics of PCT.”
Kip, M. M. A., Kusters, R., IJzerman, M. J., & Steuten, L. (2015) · Journal of Medical Economics · doi:10.3111/13696998.2015.1064934 · Cited by 74
“, Hochreiter et al.(8), Schroeder et al.”
Quenot, J., Luyt, C. E., Roche, N., Chalumeau, M., Charles, P., Claessens, Y.-É., Lasocki, S., Bédos, J., Pean, Y., Philippart, F., et al. (2013) · Annals of Intensive Care · doi:10.1186/2110-5820-3-21 · Cited by 72
“To date, 14 trials have examined the clinical impact of PCT-guided antibiotic therapy and its discontinuation [15-20,22,23,33,35,69,70,72,73].”
BackgroundPugh, R. J., Grant, C., Cooke, R. P. D., & Dempsey, G. A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007577.pub2 · Cited by 73
Debiane, L. G., Hachem, R. Y., Wohoush, I. A., Shomali, W. E., Bahu, R. R., Jiang, Y., Chaftari, A., Jabbour, J. E., Shuaibi, M. A., Hanania, A. N., et al. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000526 · Cited by 63
Ruiz‐Rodríguez, J. C., Caballero, J., Ruiz-Sanmartín, A., Ribas, V. J., Pérez-Carrasco, M., Jl, B., & Rello, J. (2012) · Medicina Intensiva · doi:10.1016/j.medin.2011.11.024 · Cited by 63
“Hochreiter discontinued antibiotic therapy if PCT dropped 25--35% of the initial value over 3 days.(31) To our knowledge, this is the first study to develop the concept of PCT-c as a tool for assessing the evolution of PCT concentrations during the course of SS and MODS.”
Schüetz, P., Bolliger, R., Merker, M., Christ‐Crain, M., Stolz, D., Tamm, M., Luyt, C. E., Wolff, M., Schröder, S., Junior, V. A. N., et al. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1496331 · Cited by 63
Jong, E. A.-D., de Lange, D. W., van Oers, J. A. H., Nijsten, M. W., Twisk, J. W. R., & Beishuizen, A. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-178 · Cited by 72
Schüetz, P., RAAD, I. I., & Amin, D. (2013) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e328363bd38 · Cited by 65
Weiss, C. H., DiBardino, D., Rho, J., Sung, N., Collander, B., & Wunderink, R. G. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e318298291a · Cited by 57
Broyles, M. R. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx213 · Cited by 62
Clinical Knowledge from Observational Studies. Everything You Wanted to Know but Were Afraid to Ask
Gershon, A. S., Jafarzadeh, S. R., Wilson, K. C., & Walkey, A. J. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201801-0118pp · Cited by 58
The Role of the Microbiology Laboratory in Antimicrobial Stewardship Programs
Avdic, E., & Carroll, K. C. (2014) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2014.01.002 · Cited by 60
Hsu, K.-H., Ming‐Chen, C. H. A. N., Wang, J., Lin, L., & Wu, C. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01876.x · Cited by 56
AACC Guidance Document on the Clinical Use of Procalcitonin
Chambliss, A. B., Patel, K., Colón-Franco, J. M., Hayden, J. A., Katz, S. E., Minejima, E., & Woodworth, A. L. (2023) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfad007 · Cited by 64
“We reviewed 5 RCTs comparing PCT-guided antibiotic duration with standard antibiotic duration (Supplemental Table 1) with sample sizes that ranged from 110 to 1546 patients (10-16, 23).”
BackgroundMethodResultInfluentialApplying biomarkers to clinical practice: a guide for utilizing procalcitonin assays
Foushee, J. A., Hope, N. H., & Grace, E. E. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks265 · Cited by 63
Georgopoulou, A.-P., Savva, A., Giamarellos‐Bourboulis, E. J., Georgitsi, M., Raftogiannis, M., Antonakos, N., Apostolidou, E., Carrer, D.-P., Dimopoulos, G., Economou, A., et al. (2010) · Journal of Critical Care · doi:10.1016/j.jcrc.2010.07.012 · Cited by 52
Plasma procalcitonin concentrations predict organ dysfunction and outcome in dogs with sepsis
Troìa, R., Giunti, M., & Goggs, R. A. N. (2018) · BMC Veterinary Research · doi:10.1186/s12917-018-1427-y · Cited by 50
Peng, F., Chang, W., Xie, J.-F., Sun, Q., Qiu, H.-B., & Yang, Y. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.05.034 · Cited by 49
Antibiotic stewardship programmes in intensive care units: Why, how, and where are they leading us
Zhang, Y. Z., & Singh, S. (2015) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v4.i1.13 · Cited by 62
A proposal for a comprehensive approach to infections across the surgical pathway
Sartelli, M., Pagani, L., Iannazzo, S., Moro, M. L., Viale, P., Pan, A., Ansaloni, L., Coccolini, F., D’Errico, M. M., Agreiter, I., et al. (2020) · World Journal of Emergency Surgery · doi:10.1186/s13017-020-00295-3 · Cited by 65
“Multiple trials have investigated the benefits of using serum PCT levels to guide whether and for how long antibiotic therapy is used-a process referred to as a PCT-guided antibiotic stewardship-in patients with infection in the ICU [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] .”
BackgroundAntimicrobial Stewardship in the Emergency Department
Bishop, B. M. (2015) · Journal of Pharmacy Practice · doi:10.1177/0897190015585762 · Cited by 52
“PCT levels have also been shown to predict bacteremia in patients presenting to the ED with pneumonia.(47) In patients admitted to the intensive care unit, serially measured PCT levels have been shown in numerous studies to be a safe and effective means to decrease antimicrobial exposure and duration of therapy in pat…”
BackgroundMaseda, E., Suárez-de-la-Rica, A., Anillo, V., Tamayo, E., García-Bernedo, C. A., Ramasco, F., Villagrán, M. J., Maggi, G., Giménez, M.-J., Aguilar, L., et al. (2014) · Journal of Critical Care · doi:10.1016/j.jcrc.2014.12.014 · Cited by 52
“The first one (including 59 patientswith complicated intra-abdominal infection) showed a significant decrease in the length of antibiotic treatment [18], but in the secondone (including 34 patients), although the length of antibiotic treatmentwas shorter in the PCT-guided group, statistical significance was not reach…”
BackgroundResultInfluentialPlasma procalcitonin concentrations are increased in dogs with sepsis
Goggs, R. A. N., Milloway, M. C., Troìa, R., & Giunti, M. (2018) · Veterinary Record Open · doi:10.1136/vetreco-2017-000255 · Cited by 48
Kip, M. M. A., van Oers, J. A. H., Shajiei, A., Beishuizen, A., Berghuis, A. M. S., Girbes, A. R. J., de Jong, E., de Lange, D. W., Nijsten, M. W., IJzerman, M. J., et al. (2018) · Critical Care · doi:10.1186/s13054-018-2234-3 · Cited by 56
Metadata
- Authors
- Hochreiter, M., Köhler, T., Schweiger, A. M., Keck, F. S., Bein, B., von Spiegel, T., & Schroeder, S.
- Affiliations
- Westküstenkliniken Brunsbüttel und Heide gGmbH (DE)
- University Hospital Schleswig-Holstein (DE)
- Venue
- Critical Care
- Published
- 2009-06-03
- Volume
- 13
- Issue
- 3
- Pages
- R83-R83
- ISSN
- 1364-8535 (ISSN-L)
- PMC
- PMC2717450
- OpenAlex
- W2109928541
- Semantic Scholar
- 269d1d25f4ebc2ac9fd79ee6e50e38b8ebd7138d
- Cited by
- 315
- References
- 29
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 10 · 2023: 13 · 2022: 10 · 2021: 22 · 2020: 9 · 2019: 16 · 2018: 21 · 2017: 32 · 2016: 18 · 2015: 23 · 2014: 18 · 2013: 28 · 2012: 32
- FWCI
- 17.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Critical Care (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Keywords
- procalcitonin, antibiotic duration, antibiotic stewardship, surgical intensive care patients, bacterial infection, systemic inflammatory response syndrome, antibiotic de-escalation, antimicrobial resistance, inflammatory markers
- MeSH terms
- Aged, Anti-Bacterial Agents, Calcitonin, Diagnosis, Differential, Female, Humans, Male, Postoperative Complications, Prospective Studies, Protein Precursors, Biomarkers, Calcitonin Gene-Related Peptide, Drug Monitoring, Systemic Inflammatory Response Syndrome, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.